Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2025


Report ID : RNR-43845 Category : Biotechnology Published Date : 2018
Publisher : GlobalInfo Research Pages : 114 Format : PDF
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Scope of the Report:
This report focuses on the Insulin Glargine in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Sanofi-Aventis
    Ganlee
    Biocon

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa

Market Segment by Type, covers
    Single Dose Vial
    Pre-filled Syringe

Market Segment by Applications, can be divided into
    Treat type 1 diabetes
    Treat type 2 diabetes

There are 13 Chapters to deeply display the global Insulin Glargine market.

Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Glargine, with sales, revenue, and price of Insulin Glargine, in 2017 and 2018;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Glargine, for each region, from 2013 to 2018;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 11, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2025;

Chapter 12 and 13, to describe Insulin Glargine sales channel, distributors, traders, dealers, appendix and data source.
Table of Contents

Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2025

1 Market Overview
1.1 Insulin Glargine Introduction
1.2 Market Analysis by Type
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.3 Market Analysis by Applications
1.3.1 Treat type 1 diabetes
1.3.2 Treat type 2 diabetes
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA
1.4.1.2 Canada
1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 Latin America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa
1.4.4.5 Nigeria
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Insulin Glargine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share
2.2 Ganlee
2.2.1 Business Overview
2.2.2 Insulin Glargine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share
2.3 Biocon
2.3.1 Business Overview
2.3.2 Insulin Glargine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share
3 Global Insulin Glargine Market Competition, by Manufacturer
3.1 Global Insulin Glargine Sales and Market Share by Manufacturer
3.2 Global Insulin Glargine Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Glargine Manufacturer Market Share
3.3.2 Top 6 Insulin Glargine Manufacturer Market Share
3.4 Market Competition Trend
4 Global Insulin Glargine Market Analysis by Regions
4.1 Global Insulin Glargine Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Glargine Sales by Regions (2013-2018)
4.1.2 Global Insulin Glargine Revenue by Regions (2013-2018)
4.2 North America Insulin Glargine Sales and Growth (2013-2018)
4.3 Europe Insulin Glargine Sales and Growth (2013-2018)
4.4 Asia-Pacific Insulin Glargine Sales and Growth (2013-2018)
4.5 Latin America Insulin Glargine Sales and Growth (2013-2018)
4.6 Middle East and Africa Insulin Glargine Sales and Growth (2013-2018)
5 North America Insulin Glargine by Countries
5.1 North America Insulin Glargine Sales, Revenue and Market Share by Countries
5.1.1 North America Insulin Glargine Sales by Countries (2013-2018)
5.1.2 North America Insulin Glargine Revenue by Countries (2013-2018)
5.2 USA Insulin Glargine Sales and Growth (2013-2018)
5.3 Canada Insulin Glargine Sales and Growth (2013-2018)
5.4 Mexico Insulin Glargine Sales and Growth (2013-2018)
6 Europe Insulin Glargine by Countries
6.1 Europe Insulin Glargine Sales, Revenue and Market Share by Countries
6.1.1 Europe Insulin Glargine Sales by Countries (2013-2018)
6.1.2 Europe Insulin Glargine Revenue by Countries (2013-2018)
6.2 Germany Insulin Glargine Sales and Growth (2013-2018)
6.3 UK Insulin Glargine Sales and Growth (2013-2018)
6.4 France Insulin Glargine Sales and Growth (2013-2018)
6.5 Russia Insulin Glargine Sales and Growth (2013-2018)
6.6 Italy Insulin Glargine Sales and Growth (2013-2018)
7 Asia-Pacific Insulin Glargine by Countries
7.1 Asia-Pacific Insulin Glargine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Insulin Glargine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Insulin Glargine Revenue by Countries (2013-2018)
7.2 China Insulin Glargine Sales and Growth (2013-2018)
7.3 Japan Insulin Glargine Sales and Growth (2013-2018)
7.4 Korea Insulin Glargine Sales and Growth (2013-2018)
7.5 India Insulin Glargine Sales and Growth (2013-2018)
7.6 Southeast Asia Insulin Glargine Sales and Growth (2013-2018)
8 Latin America, Middle East and Africa Insulin Glargine by Countries
8.1 Latin America, Middle East and Africa Insulin Glargine Sales, Revenue and Market Share by Countries
8.1.1 Latin America, Middle East and Africa Insulin Glargine Sales by Countries (2013-2018)
8.1.2 Latin America, Middle East and Africa Insulin Glargine Revenue by Countries (2013-2018)
8.2 Brazil Insulin Glargine Sales and Growth (2013-2018)
8.3 Saudi Arabia Insulin Glargine Sales and Growth (2013-2018)
8.4 Egypt Insulin Glargine Sales and Growth (2013-2018)
8.5 Nigeria Insulin Glargine Sales and Growth (2013-2018)
8.6 South Africa Insulin Glargine Sales and Growth (2013-2018)
9 Insulin Glargine Market Segment by Type
9.1 Global Insulin Glargine Sales, Revenue and Market Share by Type (2013-2018)
9.1.1 Global Insulin Glargine Sales and Market Share by Type (2013-2018)
9.1.2 Global Insulin Glargine Revenue and Market Share by Type (2013-2018)
9.2 Single Dose Vial Sales Growth and Price
9.2.1 Global Single Dose Vial Sales Growth (2013-2018)
9.2.2 Global Single Dose Vial Price (2013-2018)
9.3 Pre-filled Syringe Sales Growth and Price
9.3.1 Global Pre-filled Syringe Sales Growth (2013-2018)
9.3.2 Global Pre-filled Syringe Price (2013-2018)
9.4  Sales Growth and Price
9.4.1 Global  Sales Growth (2013-2018)
9.4.2 Global  Price (2013-2018)
10 Insulin Glargine Market Segment by Application
10.1 Global Insulin Glargine Sales Market Share by Application (2013-2018)
10.2 Treat type 1 diabetes Sales Growth (2013-2018)
10.3 Treat type 2 diabetes Sales Growth (2013-2018)
10.4  Sales Growth (2013-2018)
10.5  Sales Growth (2013-2018)
11 Insulin Glargine Market Forecast (2018-2025)
11.1 Global Insulin Glargine Sales, Revenue and Growth Rate (2018-2025)
11.2 Insulin Glargine Market Forecast by Regions (2018-2025)
11.3 Insulin Glargine Market Forecast by Type (2018-2025)
11.4 Insulin Glargine Market Forecast by Application (2018-2025)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Distributors, Traders and Dealers
13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source